Alvotech (NASDAQ:ALVOW) Short Interest Update
by Renee Jackson · The Cerbat GemAlvotech (NASDAQ:ALVOW – Get Free Report) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,032 shares, a decrease of 88.7% from the April 15th total of 9,151 shares. Based on an average daily trading volume, of 2,140 shares, the short-interest ratio is currently 0.5 days.
Alvotech Price Performance
NASDAQ:ALVOW opened at $0.25 on Thursday. The firm has a 50-day moving average of $0.28 and a two-hundred day moving average of $0.54. Alvotech has a 1-year low of $0.15 and a 1-year high of $3.00.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.